United States Cell and Gene Therapy Market 2025 | Growth Drivers, Key Players & Investment Opportunities

Market Size and growth

Cell and Gene Therapy Market size reached US$ 13.90 Billion in 2024 and is expected to reach US$ 105.83 Billion by 2033, growing at a CAGR of 21.5% during the forecast period 2025-2033.

Key Development:

United States: Recent Industry Developments

✅ In October 2025, Takeda Pharmaceutical announced its decision to discontinue all cell therapy initiatives, including its gamma delta T-cell platform, and is seeking a partner to further develop its research and clinic-ready programs in this area.

✅ In September 2025, the Advanced Research Projects Agency for Health (ARPA-H) launched a program aimed at igniting innovative biomanufacturing for cell and gene therapies, focusing on scalable manufacturing technology to make genetic medicines widely available.

✅ In September 2025, AstraZeneca announced a groundbreaking program to develop affordable precision genetic medicines for all Americans, aiming to prevent rare and common diseases with individualized targeted therapies.

Japan: Recent Industry Developments

✅ In October 2025, Takeda Pharmaceutical announced its decision to discontinue all cell therapy initiatives, including its gamma delta T-cell platform, and is seeking a partner to further develop its research and clinic-ready programs in this area.

✅ In September 2025, the Japan External Trade Organization (JETRO) launched the Japan Entry Acceleration Program (JEAP) to support startups in regenerative medicine and cell and gene therapy, providing tailored mentorship and market insights to accelerate entry, collaboration, and growth in Japan's advanced healthcare market.

✅ In May 2025, Minaris Advanced Therapies was launched as a global partner dedicated to cell therapy development, manufacturing, and testing, following the merger of Minaris Regenerative Medicine and WuXi Advanced Therapies operations in the U.S. and U.K.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/cell-and-gene-therapy-market?sb

Recent Mergers and Acquisitions:

United States: Recent M&A Developments

✅ In June 2025, AbbVie acquired Capstan Therapeutics for $2.1 billion, enhancing its cell and gene therapy capabilities through Capstan's in vivo CAR-T platform and RNA delivery technology.

✅ In June 2025, Eli Lilly advanced its genetic medicine strategy by acquiring Verve Therapeutics for $1.3 billion, gaining precision therapies for inherited cardiovascular conditions.

✅ In January 2025, Johnson & Johnson acquired Intra-Cellular Therapies for $14.6 billion in cash, strengthening its presence in central nervous system and neuropsychiatric disorders.

Japan: Recent M&A Developments

✅ In October 2025, Galapagos received non-binding offers from multiple groups, mostly financial investors, for its cell therapy division, and is considering a possible sale or divestment.

Key Players:

=> Novartis AG, Gilead Sciences, Inc., Bristol Myers Squibb Company, Vertex Pharmaceuticals Incorporated, Sarepta Therapeutics, Inc., CSL Behring LLC, Amgen, Inc., Orchard Therapeutics group, Krystal Biotech, Inc., bluebird bio, Inc., and among others. Emerging market players include Editas Medicine, Intellia Therapeutics, Rocket Pharmaceuticals, Regenxbio, Affinia Therapeutics, and others.

Growth Forecast Projected:

The Global Cell and Gene Therapy Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Cell and Gene Therapy Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cell-and-gene-therapy-market

Key Segments:

➥ By Therapy Type: Cell Therapy, Gene Therapy

➥ By Application: Oncology, Musculoskeletal Conditions, Ophthalmology, Blood Disorders, Immunodeficiency Disorders, Graft-versus-Host Disease (GVHD), Rare Diseases, Others

Regional Analysis for Cell and Gene Therapy Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Cell and Gene Therapy producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Cell and Gene Therapy revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cell-and-gene-therapy-market?sb

FAQ

What is the current size of the Cell and Gene Therapy Market?

A: In 2024, the Cell and Gene Therapy Market was valued at US$ 13.90 Billion, reflecting its strong industry presence.

Q2: How large is the Cell and Gene Therapy Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Cell and Gene Therapy Market will grow to around US$ 105.83 Billion, demonstrating significant expansion.

Q3: What is the growth rate of the Cell and Gene Therapy Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 21.5% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us
-

Company
Name: DataM Intelligence

Contact Person: Sai Kiran

Email: Sai.k@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.